cell_id,prompt,answer,output
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets LCK, which is a tyrosine kinase that is a member of the SRC family of oncogenes. The drug SMILES structure does not provide any information about the drug target pathway.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug SMILES structure does not provide any information about the drug target.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is LCK, which is a tyrosine kinase that is a member of the SRC family of oncogenes. The drug target pathway is Other, kinases.
The drug target of the drug is LCK, which is a tyrosine kinase that is a member of the SRC family of oncogenes. The drug target pathway is Other, kinases.
The mutations of the cell line do not"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is ALK. The drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, P53, U2AF1. The drug SMILES structure indicates that the drug is a kinase inhibitor.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line depends on the effect of the mutations on the cell line. If the mutations are neutral or have a positive effect on the cell line, the drug Sensitivity will be Sensitive. However, if the mutations have a negative effect on the cell line, the drug Sensitivity will be Resistant.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the effect of the drug on the cell line. If the drug causes cell death or in"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets PDK1. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing its effect on cell growth and viability. If the drug does not affect the cell line, it is Sensitive. If the drug causes cell death or growth inhibition in the cell line, it is Resistant.
Reasoning: The drug SMILES structure indicates that the drug targets PDK1. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line is Resistant. The drug SMILES structure indicates that the drug target, IGF1R, is not affected by the mutations in the cell line. The drug target pathway is also not affected by the mutations in the cell line.
The cell line mutations, ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1, do not seem to affect the drug target of the drug. The drug target pathway is also not affected by the mutations in the cell line.
The drug SMILES structure indicates that the drug target, IGF1R, is affected by the mutations in the cell line. The drug target pathway is also affected by the mutations in the cell line.
In summary, the drug sensitivity of the drug on the cell line is Resistant, as the drug target of the drug is affected by the mutations in the cell line."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is G9A, GLP. The drug target pathway is Chromatin histone methylation.
The cell line mutations include ASXL1, FLT3, MAP3K1, NOTCH1, PIK3CA, PTEN, RB1, SLC34A2, TET2, TP53.
Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant. The drug target is not related to the mutations of the cell line. The drug target pathway is also not related to the mutations of the cell line. Therefore, the drug will not affect the growth of the cell line."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a metalloenzyme inhibitor. The drug target is MTOR. The drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, P53.
Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is MTOR. The drug target pathway of the drug is PI3K/MTOR signaling.
The drug inhibits the MTOR signaling pathway by inhibiting the MTOR and AXL kinases. The MTOR signaling pathway is essential for cell growth and proliferation. The MTOR signaling pathway is also involved in the regulation of metabolism and cell survival.
The cell line mutations are ASXL1, FLT3, M"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BOSUTINIB. The drug SMILES structure is CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC. Drug target is SRC, ABL, TEC. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the mutations present in the cell line. In this case, the mutations present in the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. These mutations may affect the drug sensitivity of the drug on the cell line.
The drug SMILES structure of the drug is CN1CCN(CC1)CCCOC2=C. The drug target of the drug is SRC, ABL, TEC. The drug target pathway of the drug is Other, kinases.
Based on the mutations present in the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug may not be effective on the cell line with these mutations.
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is kinases. The drug target pathway of the drug is Other. The mutations present in the cell"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is an anthracycline, which is a class of drugs that are commonly used in chemotherapy to treat various types of cancer. The drug SMILES structure does not provide any information about the drug target or the drug target pathway.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The mutations of the drug-sensitive cell line are FLT3, MAP3K1, NF1, PIK3CA, RB1, TP53.
Based on the SMILES structure of the drug and the mutations of the cell line, the drug sensitivity of the drug on the cell line can be predicted as Resistant. The drug target of the drug is Anthracycline, which is a class of drugs that are commonly used in chemotherapy to treat various types of cancer. The drug target pathway of the drug is"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is RNA helicase A. The drug target pathway is Other. The mutations of the cell line suggest that the drug target pathway may be affected.
The drug is YK-4-279. The drug target is RNA helicase A. The drug target pathway is Other.
Based on the drug target and drug target pathway, the drug is unlikely to affect the cell line. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug target of the drug is RNA helicase A. The drug target pathway is Other. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
Based on the drug and cell line mutations provided, the drug SMILES structure, and the drug target pathway, the drug sensitivity of the drug on the cell line can be predicted to be Resistant.
The cell line mutations include ASXL1, FLT3, MAP3K1, NOTCH1, P53. The drug target is ESR1. The drug target pathway is Hormone-related.
The Resistant prediction is based on the fact that the drug target is not affected by the mutations in the cell line. The drug target pathway is not related to the mutations in the cell line. Therefore, the drug SMILES structure remains unchanged, indicating that the drug target remains untargeted by the drug.
In summary, the drug sensitivity of the drug on the cell line can be predicted to be Resistant based on the drug target, drug target pathway, and cell line mutations provided."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets unidentified targets. The drug target pathway is unidentified. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug is ABT-737.
Based on the provided information, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is Unknown. The drug target pathway of the drug is Unknown.
The cell line mutations include ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug target of the drug is Unknown. The drug target pathway of the drug is Unknown.
The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C="
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is MPS1. The drug target pathway is Mitosis.
The cell line mutations include ASXL1, FLT3, MAP3K1, NOTCH1, P53.
Based on the drug SMILES structure and the cell line mutations, the drug Sensitivity on the cell line is likely to be Resistant. The drug target is MPS1, which is a mitosis regulator. The drug target pathway is Mitosis. The drug is a kinase inhibitor.
The cell line mutations include ASXL1, FLT3, MAP3K1, NOTCH1, P53, U2AF1. The drug target is MPS1. The drug target pathway is Mitosis.
In summary, the drug Sensitivity on the cell line is likely to be Resistant due to the drug target MPS1 and the drug target pathway Mitosis. The cell line mutations also contribute to the drug resistance."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ROSCOVITINE. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line depends on the mutations present in the cell line. As the mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=CC=CC=C2N=CC1=O. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
As the drug SROCOVITINE has a target of CDK2, CDK7, CDK9. The drug target pathway is Cell cycle. The mutations present in the cell line, such as FLT3, TP53, U2AF1, do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be resistant."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SCH772984 is a ERK1, ERK2 suitability. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. Drug Sensitivity:?[/INST]Resistant.
The drug SCH772984 is a ERK1, ERK2 inhibitor. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug OTX015 is a kinase inhibitor. The drug target is BRD2. The drug target pathway is Chromatin other. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line can be determined based on the mutations of the cell line. The drug Sensitivity of the drug on the cell line is Resistant because the cell line has mutations in ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug Sensitivity of the drug on the cell line is determined by the mutations present in the cell line.
Reasoning:
The drug Sensitivity of the drug on the cell line is Resistant because the cell line has mutations in ASXL1, FLT3, MAP3K1, NOTCH1, TP"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SMILES structure is a kinase inhibitor. The drug target pathway indicates that the drug target pathway is a general kinase inhibitor. The mutations of the cell line do not seem to be related to the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line with the given mutations is likely to be resistant."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
Based on the drug and cell line mutations provided, the drug SMILES structure, and the drug target pathway, the drug sensitivity of the drug on the cell line can be predicted to be Resistant.
The drug SMILES structure indicates that the drug has a complex structure with a metabolic pathway. The drug target pathway is ERK MAPK signaling, which is involved in various cellular processes, including proliferation, differentiation, and survival. The mutations of the cell line, including ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1, suggest that the cell line may have impaired cellular processes related to DNA repair, stem cell maintenance, and proliferation.
Given the drug SMILES structure and the drug target pathway, the drug is unlikely to affect the cell line's proliferation. The mutations of the cell line, however, may affect the cell line's ability to proliferate, depending on the specific"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. The drug target pathway is Other, kinases. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, PIK3, U2AF1. The drug is PI-103.
Based on the SMILES structure and drug target, the drug target pathway, and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line depends on the specific mutations of the cell line. If the mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, PIK3, U2AF1, the drug Sensitivity of the drug on the cell line is Uncertain.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing the growth of the cell line after exposure to"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SHIKONIN is a natural product that has been shown to have anticancer properties, particularly in the context of inflammatory diseases. However, the drug SHIKONIN is not a targeted drug, meaning it does not target a specific cancer cell pathway or mechanism. Instead, it is a non-specific drug that affects various cellular processes, including DNA replication, RNA transcription, and mitochondrial function.
Based on the drug SHIKONIN and the mutations of the cell line, it is unlikely that the drug will be sensitive to SHIKONIN. The drug SHIKONIN does not target any specific cancer pathways or mechanisms, and its non-specific effects on cellular processes may not be beneficial for cancer cells with specific mutations. In fact, cancer cells with specific mutations may be more resistant to SHIKONIN due to their altered cellular pathways and mechanisms.
Therefore, based on the drug and cell line mutations, the drug SHIKONIN is likely to be resistant to the cell line."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets BRD2, BRD3, and BRD4, which are all members of the polycomb group (PcG) and are involved in chromatin remodeling and gene silencing. The drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug SMILES structure indicates that the drug targets BRD2, BRD3, BRD4.
Based on the drug target and mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is BRD2, BRD3, BRD4. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug target pathway is Chromatin other.
The drug SMILES structure indicates that the drug targets BRD2, BRD3, BRD4. The drug target path"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a chlorine-based compound with a carbon atom at the end. The drug target is unknown, and the drug target pathway is also unknown. The mutations of the cell line are FLT3, MAP3K1, NOTCH1, TP53. Based on these factors, the drug sensitivity of the drug on the cell line is likely to be resistant.
The drug SNOC1 is a potent and selective inhibitor of the enzyme poly (ADP-ribose) polymerase (PARP). PARP is a DNA damage response protein that plays a role in maintain DNAs damage response. Drug target is PARP. Drug target pathway is DNA damage response.
In conclusion, based on the drug SMILES structure and the mutations of the cell line, the drug sensitivity of the drug on the cell line is likely to be resistant."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is Unknown. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug is a kinase inhibitor, and the mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a class I HDAC inhibitor. The drug target is HDAC6, which is a class I HDAC that is involved in the deacetylation of various genetic substrates. The drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53. The drug SMILES structure indicates that the drug is ACY-1215.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is HDAC6, which is involved in the deacetylation of various genetic substrates. The drug target pathway is Chromatin histone acetylation. The mutations of the cell line, such as ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1, may affect the sensitivity of the drug on the cell line.
AC"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets GSK3B. The drug target pathway indicates that the drug targets WNT signaling. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or growth inhibition in the cell line, then the drug is likely to be sensitive. However, if the drug does not affect the cell line, then the drug is likely to be resistant.
Reasoning: The drug SMILES structure indicates that the drug targets GSK3B. The drug target pathway indicates that the drug targets WNT signaling. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a mono-Nucleophile. The drug target is TOP2. The drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, PIK3CA, PTPN11, REL, RNF43, SMARCA4, TET2, TP53.
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The drug sensitivity of the drug on the cell line is Resistant. The drug SMILES structure indicates that the drug is a mono-Nucleophile. The drug target is TOP2. The drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, FLT3, MAP"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined by the mutations present in the cell line. The mutations present in the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, PIK3CA, POLD1, SMARCB1, SOX9, TERT, TP53. The drug Sensitivity of the drug on the cell line is determined by the absence of the PIK3CA mutation. PIK3CA mutations are known to be associated with increased AKT signaling, which can lead to cell survival and proliferation. In the absence of the PIK3CA mutation, the drug Sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug Sensitivity of the drug on the cell line is determined by the mutations present in the cell line. In this case, the drug Sensitivity is Resistant. The absence of the PIK3CA mutation in the cell line means that the AKT signaling pathway is not affected, and the cell line will continue to proliferate"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a PI3K-related protein. The drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FLT3, MAP3K1, NOTCH1, TP53. The drug SMILES structure indicates that the drug is a kinase inhibitor.
Based on the drug SMILES structure and drug target, the drug is not likely to affect the drug-sensitive cell line. The drug target pathway is PI3K/MTOR signaling, which is not directly related to the mutations in the cell line.
The drug Sensitivity of the drug on the cell line would be Resistant, as the drug target is not directly related to the mutations in the cell line."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TELOMERASE INHIBITOR IX. The drug SMILES structure is C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O. Drug target is Telomerase. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line. Since the drug Sensitivity of the drug on the cell line is not determined by the mutations, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line can be determined by analyzing the effects of the drug on the cell line. The drug Sensitivity of the drug on the cell line is Resistant because the drug is not able to inhibit the telomerase enzyme, which is responsible for the growth and division of cancer cells. The drug Sensitivity of the drug on the cell line is determined by the ability of the drug to inhibit the growth of cancer cells.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line with the given mutations. The drug Sensitivity of the drug on the cell line with the given mutations is determined by the ability of the drug to inhibit the growth of cancer cells with the given mut"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a statin, which is a cholesterol-lowering drug. The drug target is unknown. The drug target pathway is unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53.
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)OC)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Based on the drug"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets mTOR. The drug target pathway is PI3K/mTOR signaling. The cell line mutations include ASXL1, FLT3, MAP3K1, NOTCH1, P53.
Based on the drug structure and drug target, the drug is likely to affect the cell line's growth. The cell line mutations, particularly FLT3, MAP3K1, and NOTCH1, may affect the cell line's ability to grow. However, the P53 mutation may have a protective effect on the cell line, as P53 is a tumor suppressor.
Based on the information provided, the drug sensitivity of the drug on the cell line is likely to be resistant. The drug target of the drug, mTOR, is a key regulator of cell growth and metabolism. The drug target pathway indicates that the drug targets the PI3K/mTOR signaling pathway. The cell line mutations, particularly FLT3, may affect the cell line's"
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CARMUSTINE. The drug SMILES structure is C(CCl)NC(=O)N(CCCl)N=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is an alkylating agent, which is not suitable for cancer treatment. The drug target is also unknown, which makes it difficult to predict the drug's effectiveness on the cell line.
The cell line mutations include FLT3, MAP3K1, NOTCH1, TP53. These mutations may affect the cell line's ability to grow and divide, and the drug SMILES structure indicates that the drug is not suitable for cancer treatment.
Based on the drug SMILES structure and the cell line mutations, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000006,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets IKK, which is a kinase that is involved in various signaling pathways, including NF-κB activation. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing the growth inhibition or induction of cell death. If the drug does not affect the growth of the cell line, then it is Sensitive. If the drug causes growth inhibition or induction of cell death in the cell line, then it is Resistant.
Reasoning: The drug SMILES structure indicates that the drug targets IKK, which is a kinase that is involved in various signaling pathways, including NF-κB activation. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or pathway"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SB-505124 is a CDK4 inhibitor. The drug target is Unknown. The drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, ETV5, FLT1, JAK1, MLL, MUTYH, NOTCH3, NOTCH1, NOTCH2, PIK3C2B, PIK3CA, POLD1, PTCH1, PTEN, RAF1, SF3B1, SMARCA4, STAG2, TP53.
The drug SB-505124 is not a kinase inhibitor, but a CDK4 inhibitor. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets JNK1. The drug target pathway is JNK and p38 signaling. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, ETV5, FLT1, KEL, MLL, MLL2, MUTYH, PIK3C2B, PIK3CA, PTEN, RAF1, SMARCA4, TP53. The drug is ZG-10.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is JNK1. The drug target pathway is JNK and p38 signaling. The mutations of the cell line, including ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a vascular endothelial growth factor receptor (VEGFR) inhibitor. The drug target pathway is RTK signaling. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug SMILES structure indicates that the drug is a vascular endothelial growth factor receptor (VEGFR) inhibitor. VEGFR inhibitors are commonly used in cancer treatment, and the drug target pathway is not related to the mutations of the cell line. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line is Resistant. The drug SMILES structure indicates that the drug SARACAT is a kinase inhibitor that targets a variety of kinases, including RET, NTRK2, NTRK3, NTRK2, KIT, PDGFR, FGFR, SDHC, HNF1A, BRCA, REL, MYC. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, NTRK2, PDGFR, SMARCA4, TP53. The drug SARACAT is a kinase inhibitor that targets a variety of kinases, including RET, NTRK2, NTRK3. Drug target pathway is Other.
The drug SARACAT is not a"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is Stearoyl-CoA desaturase. The drug target pathway is Other. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53. The drug is CAY10566.
Based on the drug target and mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is not related to the mutations of the cell line. Therefore, the drug will not be affected by the mutations of the cell line.
Reasoning:
The drug SMILES structure indicates that the drug target is Stearoyl-CoA desaturase. The drug target pathway is Other. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMAR"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0941. The drug SMILES structure is CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6. Drug target is PI3K (class 1). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARACAT is a PI3K (class 1) inhibitor. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SARACAT is a PI3K (class 1) inhibitor. PI3K (class 1) inhibitors are commonly used in cancer treatment, particularly in combination with other drugs. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
In summary, the drug sensitivity of the drug SARACAT on the cell line with given mutations"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets LSD1, HDAC1, HDAC6. The drug target pathway is Chromatin histone acetylation. Drug target is Metal-associated.
The mutations of the cell line are ALK, AR, ATM, ATR, BRAF, CSF1R, DDR1, DOT1L, EPHB1, ERBB2, ERBB3, FLT1, GNAS, IKZF1, KDM5A, KIT, MLL, MLL2, MED12, MSH6, NF1, NTRK1, PARK2, PMS2, PTCH1, RNF43, RPTOR, SF3B1, SMARCA4, SMARCB1, SMARCA5, TP53, XPO1.
Based on the"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug SMILES structure indicates that it is an alkylating agent, which means it interferes with DNA replication by adding an alkyl group to the DNA. The drug target is DNA alkylating agent. The drug target pathway is DNA replication.
The mutations present in the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, ETV6, FLT1, FLT3, GRM3, IKZF1, KDM5C, KDM6A, KIT, MLL2, MED12, MSH6, MST1R, MYCL1, NOTCH1, NTRK2, PIK3C2B, PIK3CA, PTEN, RAC1, RAF1, RB1, SLC34A2, SMARCA4, SOCS1, TET2, TP53.
Based on the mutations present in the cell line, the drug SMILES structure, and"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets LRRK2 and ERK5. The drug target pathway is Other, kinases. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, ETV5, FLT1, GNA13, MLL, MED12, MSH2, MTOR, MYC, NOTCH1, NTRK1, PIK3C2B, PIK3CA, POLD1, PTEN, RAF1, ROS1, SMO, TBX3, TIPARP, TP53.
Based on the drug target and mutations of the cell line, the drug SMILES structure, and the drug target pathway, the drug sensitivity of the drug on the cell line can be predicted as Resistant. The drug may not be effective in suppressing the growth of the cell line with the mutations."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a metal-based compound consisting of a metal ion linked to a series of ligands. The drug target is unknown, and the drug target pathway is also unknown. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, EMSY, EP300, ERBB3, FANCA, FLT3, HGF, KDM5C, MLL, MAP3K1, MLL2, MTOR, MYC, NFE2L2, NTRK1, PIK3C2G, PIK3CA, PTPN11, RNF43, SMARCA4, TET2, TP53.
Based on the drug SMILES structure and the mutations of the cell line, the drug sensitivity of the drug on the cell line can be predicted as Resistant. The drug target of the drug is unknown, and the drug target pathway is also unknown. The mut"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a LETM. The drug target pathway is Mitosis.
The mutations of the cell line are ALK, AR, ATM, ATR, ATRX, BAP1, BRAF, BRCA2, BRD4, BTK, CASP8, CBFB, CSF3R, CTNNA1, CXCR4, DDR1, DNMT3A, EP300, EPHB4, ERBB2, ERBB3, ETV6, FANCA, FBXW7, FGF12, FGF14, FGFR2, FLT1, GNA11, GNAS, HGF, IKBKE, INPP4B, IRS2, JAK1, JAK"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is AKT1, AKT2, and AKT3. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The drug is AZD5363. Drug target is PI3K (class 1), PI3K (class 1), PI3K (class 1). Drug target"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is RNA helicase A. The drug target pathway is Other. The mutations of the cell line suggest that the drug target is not affected by the mutations. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: Resistant."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure provides information about the drug molecule, but it does not provide any information about the drug target or the target pathway. The drug target of the drug is TGFB1. The drug target pathway is Other.
The cell line mutations provide information about the mutations present in the cell line, but it does not provide any information about the drug sensitivity of the drug on the cell line. The drug sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing the growth inhibition or induction of cell death.
Based on the information provided, the drug sensitivity of the drug on the cell line is Resistant. The drug is likely to have little to no effect on the cell line due to the presence of mutations in ALK, AR, ATM, BRCA2, CSF1R, KDM5C, MLL, MUTYH, NF1, PIK3C2G, PTEN, ROS1, SMAD4, TP53."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAP-232, TT-232, TLN-232. The drug SMILES structure is CC(C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)O. Drug target is Glycolysis. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets glycolysis, which is the process of converting glucose to pyruvate. The drug SMILES structure does not provide any information about the drug target pathway. The mutations of the cell line do not provide any information about the drug sensitivity of the drug on the cell line.
The drug is sensitive to the drug SMILES structure. The drug SMILES structure does not provide any information about the drug target pathway. The drug target is Glycolysis. The drug target pathway is Metabolism.
The drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is Glycolysis. The drug target pathway is Metabolism. The mutations of the cell line do not provide any information about"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYCLOPHOSPHAMIDE. The drug SMILES structure is C1CNP(=O)(OC1)N(CCCl)CCCl. Drug target is Alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line depends on the mutations present in the cell line. The drug SMILES structure indicates that it is an alkylating agent, which means it interferes with DNA replication by adding alkyl groups to DNA. However, the drug target is not specified.
The mutations present in the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, ETV5, FLT1, JAK2, MLL, MUTYH, NOTCH3, NOTCH1, NOTCH2, PIK3C2G, PIK3CA, PTPN11, ROS1, SMARCA4, TP53.
The drug SMILES structure does not provide any information about the drug target or the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line cannot be determined based on the SMILES structure alone. The drug sensitivity of the drug on the cell line would require additional information about the drug target and the drug target pathway.
In summary, the drug sensitivity of the drug on the cell line depends on the mutations present in the cell line."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-BEZ235. The drug SMILES structure is CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure provides information about the drug target and the drug target pathway. The drug target, PI3K (class 1), is a common target for anticancer drugs. The drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line provide information about the genetic alterations that are driving the growth of the tumor. However, the drug sensitivity of the drug on the cell line depends on various factors, including the drug target, drug target pathway, and the genetic alterations of the cell line.
Based on the SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is likely to be Resistant. The drug target of the drug, PI3K (class 1), is not directly related to the genetic alterations of the cell line. However, the drug target pathway of the drug, P"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARM1, MTOR, ATR, PKD2. Drug target is PDGFR, PDGFRA. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ATM, ATR, BRAF, CIC, CREBBP, CTCF, DOT1L, EGFR, EP300, ETV5, FGF12, FLT1, FLT3, GRM3, IGF1R, IKZF1, KDM5A, KIT, MLL, MLL2, MED12, MSH2, MTOR, NTRK1, PARK2, PARP2, PDCD1, PIK3C2B, PIK3CA, POLD1, PTCH1, PTEN, RAC1, RAF1, RB1, SMARCA4"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is an inhibitor of dihydrofolate reductase. The drug target pathway is DNA replication. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, ETV5, FLT1, GNA13, MLL, MTOR, PIK3C2G, PIK3CA, PTEN, ROS1, SMARCA4, TP53.
Based on the drug and cell line mutations provided, the drug SMILES structure, and the drug target pathway, the drug sensitivity of the drug on the cell line can be predicted as Resistant.
The drug SMILES structure indicates that the drug inhibits dihydrofolate reductase. However, the mutations of the cell line, including ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, MLL, MTOR, PIK3C2G, PIK3CA, PTEN, R"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-216763. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl. Drug target is GSK3A, GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SB-216763 is a GSK3A inhibitor. The drug target is GSK3A. The drug target pathway is WNT signaling.
The cell line mutations are ALK, AR, ATM, ATR, AXL, BRAF, BRCA2, CSF1R, CDK4, CREBBP, CSF3R, CTCF, CUL4A, DOT1L, FGF3, FGFR2, GNA13, GNAS, JAK1, KDM5A, KIT, MLL, MLL2, MAP2K4, MED12, MSH6, MYC, NOTCH1, NOTCH3, PIK3C2G, PIK3R1, POLD1, PPP2R1A, PRKAR1A, PTEN, RAC1, RAF1, RB1, RBM10, ROS1, SMAD4, SPEN, SRC"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SHIKONIN is a natural product that has been shown to have anticancer properties, particularly in the context of inflammation and immune disorders. However, the drug SHIKONIN is not a targeted drug, and its mechanism of action is not well understood. Therefore, it is possible that the drug SHIKONIN may have a broad impact on cellular processes and could potentially affect cancer cells as well as other cells in the body.
The cell line mutations provided include ALK, AR, ATM, ATR, BAP1, BRAF, CALR, CDKN2A, CHEK2, FAM46C, KDM5A, MLL, MSH6, NOTCH2, PIK3C2B, PIK3CA, PTEN, ROS1, SMAD4, TERT, TP53.
Based on the drug and cell line mutations provided, the drug SHIKONIN is unlikely to affect the cell line. The drug SHIKONIN is a natural product that has been shown to have anticancer properties, but its mechanism of action is not well understood. The"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a polycyclic compound consisting of 11 carbon atoms with alternating double bonds. The drug target is unknown, and the drug target pathway is also unknown. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, Crohn, Cytidine, DDR1, DOT1L, EPHB1, ERBB3, EZH2, FANCA, FBXW7, FGF12, FLT1, FLT3, GNA11, GNAS, HDAC1, HNF1A, IKZF1, KDM5A, KIT, MLL2, KRAS, MED12, MRE11A, MSH6, MST1R, MTOR, PIK3C2G, PIK3R1, PRKCI, PTEN, RAD5"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line would be Resistant, as the mutations present in the cell line, ALK, AR, ATM, ATR, AXIN1, BRAF, BRCA2, CARD11, CDH1, CDKN2A, DAXX, FANCL, FLT3, GNA13, KDM5A, KIT, MLL, MKNK1, MRE11A, MSH2, MTOR, NF1, NOTCH2, PIK3C2G, PIK3CA, PPARG, PTCH1, RAD52, RET, ROS1, SETD2, SF3B1, SMAD4, SMO, SPEN, TEK, TIPARP, TP53, WHSC1L1 would not affect the drug sensitivity of the drug on the cell line.
"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"  Resistant.
The drug Sensitivity of the drug on the cell line is Resistant. The drug Sensitivity is determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line with given mutations is determined based on the drug target pathway.
The drug target of the drug is RNA polymerase. The drug target pathway is Other. The drug target is"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target, MRCKB, is a microtubule-related protein. The drug target pathway is Cytoskeleton. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, EMSY, EP300, EPHA3, ETV6, KDM5C, MLL, MAP3K1, MED12, MSH3, MTOR, NF2, NOTCH1, NOTCH3, NTRK2, PIK3C2B, PIK3CA, POLD1, PTCH1, PTEN, RAD54L, RB1, SF3B1, SMAD4, SMARCA4, SPEN, TET2, TIPARP, TSC2, ZNF217.
Based on the drug and cell line mutations provided, the drug Sensitivity of the drug on the cell line is likely to be Resistant. The drug target of the drug is MRCKB."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is STF-62247. The drug SMILES structure is CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3. Drug target is Autophagy inducer. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is an autophagy inducer. Autophagy is a cellular process that degrades damaged or dysfunctional cellular components, including proteins and organelles. Inducing autophagy can help protect cells against stress and toxicity.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, EPHB1, ETV5, ETV6, FANCA, FBXW7, FGF12, FGF14, FGFR2, FLT1, FLT3, GNA11, HDAC1, HNF1A, IKBKE, KDM5A, MLL, MLL2, MAP2K4, MTOR, NF1, NOTCH2, PIK3C2B, PIK3CA, POLD1, PTCH1, PTEN, RB1, RET, RICTOR, RPTOR, SETD2, SMAD2, SMARCA4, SOX9, TP5"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target is HSP90. The drug target pathway is Protein stability and degradation. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, DOT1L, EPHB1, ERBB3, ERG, FBXW7, GNAS, HDAC1, HNF1A, KIT, KLHL6, MLL, MLL2, MED12, MSH2, MSH3, MTOR, NFE2L2, NOTCH1, NOTCH3, PIK3C2G, PIK3R1, POLD1, PTCH1, QKI, RNF43, SMAD4, SMARCA4, SPEN, TP53, TSC2, ZNF217. The drug target is none of the drug targets mentioned is affected by the drug. The drug target pathway is none of the drug target pathways mentioned is affected by the drug."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SUNITINIB is C1=CC(=C2C=C(C=C2)C(=O)NS(=O)(=O)C3=CC=CC4=C3C=C(C=C4)Cl)N. Drug target is PDGFR, KIT, VEGFR, FLT3, RET. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ATM, ATR, BRAF, CASP8, CREBBP, CTCF, DOT1L, EGFR, EP300, ETV5, FANCA, FH, FLT1, FLT3, GNAS, HDAC1, HNF"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the drug target of the drug and the mutations present in the cell line.
The drug target of the drug is HSP90. The drug target pathway is Protein stability and degradation.
The mutations present in the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, CSDA, MLL, MUTYH, SMARCA4, TP53.
The drug is not targeting the mutations present in the cell line. Therefore, the drug Sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug target of the drug is HSP90. The drug target pathway is Protein stability and degradation. The drug target is not related to the mutations present in the cell line. Therefore, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is LRRK2. The drug target pathway is Other, kinases.
The cell line mutations include ALK, AR, ATM, ATR, BRAF, CREBBP, CSF1R, DDR1, EPHB1, FGF10, FLT3, GRM3, IGF1R, KDR, KIT, MLL2, KRAS, MED12, MLH1, MSH6, MST1R, MTOR, NTRK1, PIK3CA, PMS2, PTEN, ROS1, SLC34A2, TP53.
The drug Sensitivity of the drug on the cell line would depend on the specific drug target and pathway of the drug. However, based on the mutations of the cell line, the drug Sensitivity would be Resistant. The drug would likely inhibit the kinases that are involved in the"
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target, MEK5, ERK5, is not affected by the mutations in the cell line. The drug target pathway is also not affected by the mutations. Therefore, the drug sensitivity of the drug on the cell line is Resistant.
The cell line mutations are ALK, AR, BRCA2, CSF1R, MUTYH, SMARCA4. The drug target of the drug is MEK5, ERK5. The drug target pathway is ERK MAPK signaling.
The drug is BIX02189. The drug target is MEK5, ERK5. The drug target pathway is ERK MAPK signaling.
The Resistant decision is based on the fact that the drug target of the drug is not affected by the mutations in the cell line. Therefore, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000021,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is IKK. The drug target pathway is Other, kinases.
The cell line mutations include ALK, AR, ATM, ATR, BRAF, CREBBP, CSF1R, DDR1, EPHB1, ERBB3, ERG, FBXW7, FLT1, GNAS, HGF, IGF1R, JAK1, KIT, MLL2, KRAS, MED12, MSH6, NOTCH1, NTRK1, PIK3CA, PMS2, PPP2R1A, RET, RNF43, ROS1, SMO, TP53, WHSC1L1.
The drug Sensitivity of the drug on the cell line with given mutations would depend on the specific drug target and the drug target pathway. In this case, the drug target is IKK, which is not directly related to the mutations in"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target LCK. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is JW-7-24-1. The drug target is LCK. The drug target pathway is Other, kinases.
Drug Sensitivity: Resistant.
Reasoning: The drug target LCK is a kinase that is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that ERK5-IN-1 is a kinase inhibitor. However, the drug target of ERK5-IN-1 is the ERK5 (BMK1), which is a member of the MAPK family. The MAPK pathway regulates various cellular processes, including proliferation, differentiation, and survival.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug Sensitivity of the drug on the cell line is unknown, as the mutations of the cell line do not provide any information about how the drug will affect the cell line.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing its effect on cell proliferation. If the drug inhibits the proliferation of the cell line, then it is Sensitive. If the drug does not inhibit the proliferation of the cell line, then it is Resistant.
Reasoning: The drug Sensitivity of"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is metabolized by CYP2C9 and CYP3A4. The drug target pathway indicates that the drug targets other kinases. The mutations of the cell line do not seem to be related to the drug target or drug metabolism. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is different from the drug target of the drug. The mutations of the cell line do not seem to be related to the drug target or drug SMILES structure. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a kinase, and the target pathway is a kinase-related. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SENSITIVITY OF THE DRUG ON THE CELL LINE WITH GIVEN MUTATIONS CAN BE DETERMINED BY EXAMINING THE MUTATIONS AND DRUG TARGET. IF THE MUTATIONS ARE NOT RELATED TO THE DRUG TARGET, THE DRUG SENSITIVITY OF THE DRUG ON THE CELL LINE IS LIKELY TO BE UNAFFECTED."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets the PDK1 protein, which is a kinase that plays a crucial role in insulin signaling. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to affect the drug target, but rather other pathways.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line's growth and viability. If the drug causes a decrease in the cell line's growth and viability, then it is considered sensitive. If the drug does not affect the cell line's growth and viability, then it is considered resistant.
Based on the information provided, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target, IGF1R, is not affected by the mutations in the cell line. The drug target pathway is also not affected by the mutations. Therefore, the drug sensitivity of the drug on the cell line is likely to be resistant.
The cell line mutations are ARFRP1, IRS2, NBN, WHSC1L1. The drug SMILES structure indicates that the drug target, IGF1R, is not affected by the mutations in the cell line. The drug target pathway is also not affected by the mutations.
Therefore, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FTY-720. The drug SMILES structure is CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N. Drug target is S1P. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets S1P. The drug target pathway is Other. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line depends on the specific drug target and the mutations present in the cell line. In this case, the drug target is S1P, and the mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug target pathway is Other.
The ARFRP1 mutation may affect the MAPK signaling pathway. The IRS2 mutation may affect the PI3K/AKT signaling pathway. The NBN mutation may affect the DNA repair pathway. The WHSC1L1 mutation may affect the kinases and TKIs signaling pathway.
The drug Sensitivity of the drug on the cell line with these mutations is Resistant, as the drug target is not affected by the mutations in the cell line. The drug target pathway is not affected by the mutations in the cell line.
In summary, the drug S"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a potent and selective G9A inhibitor. However, the drug target pathway is Chromatin histone methylation. The drug target is not related to the mutations of the cell line.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug SMILES structure indicates that the drug is a potent and selective G9A initer. However, the mutations of the cell line do not seem to be related to the drug Sensitivity.
Based on the SMILES structure and drug target pathway, the drug is not related to the mutations of the cell line. Therefore, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a JNK1, JNK2, JNK2 inhibitor. The drug target pathway is JNK and p38 signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity on the cell line is likely to be Resistant. The drug target is JNK1, JNK2, JNK2 inhibitors. JNK2 is a member of the MAPK family, which is commonly activated in various cell types, including cancer cells. JNK2 is involved in various cellular processes, including proliferation, differentiation, and survival.
The JNK2 inhibitor, AS601245, is a potent and selective inhibitor of JNK2. JNK2 is activated in various cellular processes, including proliferation, differentiation, and survival. The inhibition of JNK2 by AS6"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line depends on the mutations present in the cell line. The mutations provided are ARFRP1, IRS2, NBN, WHSC1L1. The drug SMILES structure indicates that it is an anthracycline, which is a class of drugs that are commonly used to treat various types of cancer. However, the mutations present in the cell line may affect the drug sensitivity.
The ARFRP1 mutation may affect the stability of the mitochondrial DNA, leading to impaired mitochondrial function and cell death. The IRS2 mutation may affect the insulin signaling pathway, leading to impaired glucose metabolism and cell growth. The NBN mutation may affect the stability of the NM23H1 and PIK3C2A genes, leading to impaired cell growth and division. The WHSC1L1 mutation may affect the stability of the WHSC1L1 gene, leading to impa"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is RNA helicase A. The drug target pathway is Other. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing the growth inhibition or induction of cell death. If the drug does not affect the growth of the cell line, then it is Sensitive. If the drug causes growth inhibition or induction of cell death in the cell line, then it is Resistant.
Reasoning: The drug SMILES structure indicates that the drug target is RNA helicase A. The drug target pathway is Other. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target PLK3 is affected by the drug. However, the mutations of the cell line do not seem to be related to the drug target. Therefore, the drug sensitivity of the drug on the cell line is likely to be determined by other factors, and the drug is likely to be resistant to the drug.
Reasoning: The drug SMILES structure indicates that the drug target PLK3 is affected by the drug. However, the mutations of the cell line do not seem to be related to the drug target. Therefore, the drug sensitivity of the drug on the cell line is likely to be determined by other factors, and the drug is likely to be resistant to the drug."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets unidentified targets. The drug target pathway is unknown. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug is ABT-737. The drug target is Unknown. The drug target pathway is Unknown.
Based on the provided information, the drug Sensitivity of the drug on the cell line is Resistant. The drug Sensitivity is determined by the drug target pathway and the mutations of the cell line. In this case, the drug target pathway is unknown, and the mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. These mutations do not seem to be related to the drug target pathway, and therefore, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets the MPS1 protein. The drug target pathway is Mitosis. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug SMILES structure indicates that the drug targets the MPS1 protein. The drug target pathway is Mitosis. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
Reasoning:
The drug SB-525334 is a CDK4 inhibitor. The drug SMILES structure indicates that the drug target is Unknown. The drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug Sensitivity of the drug on the cell line is unknown.
The drug SB-525334 is not a kinase inhibitor, but a CDK4 inhibitor. The drug target is Unknown. The drug target pathway is Unknown.
The mutations of the cell line do not seem to be related to the drug target of SB-525334. Therefore, the drug sensitivity of the drug on the cell line is uncertain.
Drug Sensitivity: Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ROSCOVITINE. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
Reasoning:
Based on the drug and cell line mutations provided, the drug Sensitivity of the drug on the cell line is likely to be Resistant.
ROSCOVITINE is a CDK2, CDK7, CDK9 inhibitor. The drug target pathway is Cell cycle. The drug target is Kinases.
The cell line mutations provided are ARFRP1, IRS2, NBN, WHSC1L1. The drug SMILES structure indicates that the drug inhibits CDK2, CDK7, CDK9. The drug target pathway is Cell cycle.
Given the drug target and drug target pathway, the drug Sensitivity of the drug on the cell line is likely to be Resistant. The cell line mutations may or may not have an impact on the drug sensitivity, but in this case, the drug Sensitivity is more likely to be Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a non-classical kinase inhibitor. The drug target is unknown. The drug target pathway is unknown. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Based on the information provided, the drug is likely to be resistant to the drug. The drug target is not identified, and the drug target pathway is not identified. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The mutations may or may not be related to the drug sensitivity of the drug on the cell line, but the drug target and pathway are not known, which suggests that the drug may not affect the cell line.
Reasoning:
The drug SMILES structure indicates that the drug is a non-classical kinase inhibitor. The drug target is unknown. The drug target pathway is unknown. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The mutations of the cell line may or may not be related to the drug sensitivity of the drug on the cell line, but the drug target and pathway are not known"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug STAIRS5412 is a PI3K (beta sparing) inhibitor. The drug SMILES structure is C1=CC(N=C(N1)C=CN2C3=CC4=C(C=C3)C(=CC=N4)C(C)(C)C=O)N. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug STAIRS5412 is not a kinase inhibitor, but a PI3K (beta sparing) inhibitor. The drug SMILES structure indicates that it inhibits the PI3K (beta sparing) pathway.
Based on the drug SMILES structure and the mutations of the cell line, the drug STAIRS5412 is not likely to affect the drug sensitivity of the cell line. The drug STAIRS"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a DNA-PKCls inhibitor. The drug target pathway is DNA repair. The mutations of the cell line do not seem to be related to the drug target pathway or drug SMILES structure. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets a key regulator of cell proliferation and survival. However, the drug target pathway is not affected in the cell line with the given mutations. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug SMILES structure indicates that the drug targets a key regulator of cell proliferation and survival. However, the drug target pathway is not affected in the cell line with the given mutations. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Based on the drug structure and target, the drug is unlikely to affect the cell line. The mutations of the cell line do not seem to be related to the drug. Therefore, the drug sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug SMILES structure indicates that the drug is a pyrimidine synthesis in SMILES inhibitor. The drug target pathway is DNA replication. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VOXTALISIB. The drug SMILES structure is CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N. Drug target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets PI3K (class 1), DNAPK, MTOR. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Based on the drug structure and drug target, the drug is unlikely to affect the cell line.
The drug Sensitivity of the drug on the cell line can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or inhibits cell growth, then the drug is sensitive. If the drug does not affect the cell line, then the drug is resistant.
In this case, the drug is resistant to the cell line. The drug Sensitivity of the drug on the cell line is Resistant."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined by the mutations present in the cell line. The mutations present in the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The drug Sensitivity of the drug on the cell line is determined by the drug target and"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a chlorine-based compound with a carbon atom at the end. The drug target is unknown, and the drug target pathway is also unknown. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Based on the information provided, the drug is likely to be resistant to the drug. The drug SMILES structure does not provide any clues about the drug target or pathway, which makes it difficult to predict the drug sensitivity of the drug on the cell line. The mutations of the cell line are also not related to the drug target or pathway. Therefore, the drug Sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug SMILES structure does not provide any clues about the drug target or pathway. The drug target is unknown, and the drug target pathway is also unknown. The mutations of the cell line are not related to the drug target or pathway. Therefore, the drug Sensitivity of the drug on the cell line is Resistant.
Drug Sensitivity"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is unknown. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is likely to be Resistant. The drug inhibits the kinases that are involved in the PI3K/MTOR signaling pathway. The PI3K/MTOR signaling pathway is often affected in various types of cancer, including breast cancer. Therefore, the drug Sensitivity of the drug on the cell line with given mutations is likely to be Resistant.
Reasoning:
The drug Sensitivity of the drug on the cell line is Resistant because the drug inhibits the kinases that are involved in the PI3K/MTOR signaling pathway. The PI3K/MTOR signaling pathway is often affected in various types of cancer, including breast cancer. Therefore, the drug Sensitivity of the drug on the cell line with given mutations is likely to be Resistant"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is GSK3B. The drug target pathway is WNT signaling. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing the growth inhibition or induction of cell death. If the drug does not affect the growth of the cell line, then it is Sensitive. If the drug causes growth inhibition or induction of cell death in the cell line, then it is Resistant.
Reasoning: The drug SMILES structure indicates that the drug target is GSK3B. The drug target pathway is WNT signaling. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QUIZARTINIB. The drug SMILES structure is CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3. Drug target is FLT3. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined by the mutations present in the cell line. The mutations present in the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug Sensitivity of the drug on the cell line with these mutations is Resistant.
The drug Sensitivity is determined by the SMILES structure of the drug and the mutations present in the cell line. The SMILES structure of the drug is CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3. Drug Target is FLT3. Drug Target Pathway is RTK signaling.
The drug Sensitivity of the drug on the cell line is Resistant because the mutations present in the cell line do not affect the drug target. The drug target is FLT3, which is not affected by the mutations present in the cell"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is PI3K3CG. The drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug Sensitivity of the drug on the cell line is unknown.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug Sensitivity of the drug on the cell line is Sensitive, then the drug will inhibit the growth of the cell line. If the drug Sensitivity of the drug on the cell line is Resistant, then the drug will not inhibit the growth of the cell line.
Based on the SMILES structure and drug target pathway of the drug, the drug is likely to inhibit the growth of the cell line. However, the drug Sensitivity of the drug on the cell line with given mutations depends on the specific mutations of the cell line.
Reasoning: The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyz"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TELOMERASE INHIBITOR IX. The drug SMILES structure is C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O. Drug target is Telomerase. Drug target pathway is Genome integrity.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug inhibits telomerase, which is an enzyme that helps to maintain the length of telomeres, which are the protective endcaps of chromosomes. Cancer cells have a high rate of telomere shortening, which can lead to cellular senescence or apoptosis. However, not all cancer cells are sensitive to telomerase inhibitors, and the sensitivity of cancer cells to these drugs can vary depending on the specific type of cancer and the mutations present in the cell.
The mutations present in the cell line, ARFRP1, IRS2, NBN, WHSC1L1, do not seem to be related to the drug sensitivity. However, the drug Sensitivity of the drug on the cell line can be affected by other factors, such as the expression of other genes that are involved in the same pathways as the mutated genes.
In summary, the drug Sensitivity of the drug on the cell line is Resistant, as the drug inhibits telomerase, which is not targeted by the mutations in the cell line."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VELIPARIB. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets PARP1 and PARP2, which are poly (ADP-ribose) polymers. The drug target pathway is Genome integrity. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant. 
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is PARP1 and PARP2, which are poly (ADP-ribose) polymers. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is mTOR. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Based on the drug target, drug target pathway, and mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line can be determined by analyzing the drug target of the drug and the mutations of the cell line. If the drug target is affected by the mutations of the cell line, then the drug Sensitivity of the drug on the cell line is Resistant. However, if the drug target is not affected by the mutations of the cell line, then the drug Sensitivity of the drug on the cell line is Sensitive.
In this case, the drug target of the drug is mTOR. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WH"
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-702. The drug SMILES structure is C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F. Drug target is p38. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that VX-702 is a p38alpha inhibitor. The drug target pathway is JNK and p38 signaling. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant. The drug target of VX-702 is p38alpha. The p38alpha pathway is involved in various cellular processes, including inflammation, stress responses, and proliferation. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000045,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is HSP90. The drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug Sensitivity of the drug on the cell line is unknown, as the mutations of the cell line do not provide any information about the drug sensitivity.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the drug target and the mutations of the cell line. In this case, the drug target is HSP90, which is a chaperone that regulates the folding of proteins. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug Sensitivity of the drug on the cell line with these mutations is unknown.
Reasoning: The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the drug target and the mutations of the cell line. In this case, the drug target is"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-082996. The drug SMILES structure is CCNC1=CC(=NC(=N1)NC2=CC3=C(C=C2)N(C=C3)CC4=CC=CC=C4)NC5CCC(CC5)O. Drug target is CDK4. Drug target pathway is Cell cycle.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line with given mutations is determined by evaluating the effect of the drug on the cell line's growth. If the drug causes cell line growth inhibition, the drug Sensitivity is Resistant. If the drug does not affect the cell line's growth, the drug Sensitivity is Sensitive.
In this case, the cell line has multiple mutations, including ARAF, BTK, ETV5, FLT1, MTOR, NPM1, PIK3CA, PTEN, RB1, SMARCA4, TP53. The drug Sensitivity of the drug on the cell line is Resistant, as the drug Sensitivity of the drug on the cell line with given mutations is determined by evaluating the effect of the drug on the cell line's growth. In this case, the drug causes cell line growth inhibition, indicating that"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line with given mutations is determined by evaluating the drug target of the drug and the mutations present in the cell line. In this case, the drug target of the drug is EGFR, ERBB4. The mutations present in the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug target of the drug is not related to the mutations present in the cell line. Therefore, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is RNA Polymerase 1. The drug target pathway is Other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug SMILES structure indicates that the drug is a RNA polymerase inhibitor.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug will not inhibit the RNA polymerase of the cell line, as the RNA polymerase of the cell line is not affected by the drug SMILES structure. The drug will inhibit the kinases of the cell line, which may lead to uncontrolled cell growth and division.
The drug Sensitivity of the drug on the cell line"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is Stearoyl-CoA desaturase. The drug target pathway is Other. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SCALEIN is a metabolism-based drug that affects the desaturation of fatty acids. The drug target is Stearoyl-CoA desaturase. The drug target pathway is Other.
In conclusion, based on the drug target, drug target pathway, and mutations of the cell line, the drug SCALEIN is unlikely to affect the drug sensitivity of the drug on the cell line. Therefore, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is PLK3. The drug target pathway is Cell division. The mutations of the cell line are not related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line would be Resistant, as the mutations present in the cell line, ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53, would not be affected by the drug. The drug Sensitivity of the drug on the cell line would remain unchanged."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is ERK1, ERK2. The drug target pathway is ERK MAPK signaling. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is FR-180204. The drug is a kinase inhibitor that targets the ERK1, ERK2. Drug target pathway is ERK MAPK signaling. Drug target is MET.
---
Sensitive."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined by the mutations present in the cell line. The mutations in the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug Sensitivity of the drug on the cell line is determined by the drug target and the mutations present in the cell line. In this case, the drug target is ERK1, ERK2. The mutations present in the cell line, such as ARAF, BTK, DOT1L, EGFR, ETV5, NPM1, SMARCA4, TP53, do not affect the drug Sensitivity of the drug on the cell line.
The drug Sensitivity of the drug on the cell line is Resistant because the drug target is not affected by the mutations present in the cell line. The drug target is ERK1,"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line would be Resistant, as the mutations present in the cell line, ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53, would not be affected by the drug. The drug target of the drug is EGFR. The drug target pathway is EGFR signaling.
The drug target of the drug, CD47, is a protein that is involved in immune evasion and is overexpressed in many cancer cells. The mutations present in the cell line, ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53, would not be affected by the drug target. Therefore, the drug sensitivity of the drug on the cell line would be Resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure provides information about the drug molecule, which is a kinase inhibitor. The drug target is RAS effector. The drug target pathway is RTK signaling.
The cell line mutations provide information about the mutations present in the cell line. However, the drug sensitivity of the drug on the cell line depends on various factors, including the drug target, the drug molecule, and the cell line mutations. In this case, the drug target is a RAS effector, which is a key regulator of cell growth and division. The drug molecule is a kinase inhibitor that targets various kinases, including ROS1, SRC, FLT3, FGFR1, FGFR3, PDGFRB, KIT, TBX3, TEK, ETV6, NTRK1, NTRK2, NTRK3, ATR, MYC, BRAF, MLL, MCL1, CSF3R, BTK, INPP4B, ZNF2"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is Unknown. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug is a kinase inhibitor, and the mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets the PB1 protein. The drug target pathway is Chromatin other. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be resistant.
The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The drug is PFI-3. Drug target is PB1. Drug target pathway is Chromatin other.
The cell line mutations are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug SMILES structure indicates that the drug targets the PB1 protein. The drug target pathway is Chromatin"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets EGFR. The drug target pathway is EGFR signaling. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The drug is AZD3759. The drug target is EGFR. The drug target pathway is EGFR signaling.
The drug is not related to the mutations of the cell line. The drug target is not affected by the mutations. Therefore, the drug sensitivity of the drug on the cell line is likely"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target SYK is not affected by the mutations in the cell line. The drug target pathway is also not affected by the mutations. Therefore, the drug sensitivity of the drug on the cell line is Resistant.
The cell line mutations are not related to the drug target or pathway. The mutations are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The mutations are not associated with the drug sensitivity.
The drug target of the drug is SYK. The drug target pathway is Other, kinases. The mutations in the cell line do not affect the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is C-75. The drug SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. Drug target is FAS. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug C-75 is a topoisomerase I inhibitor. The drug target of the drug is FAS. The drug target pathway of the drug is Apoptosis regulation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug SMILES structure of the drug is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O.
The drug C-75 is a drug that inhibits the topoisomerase I. The drug target of the drug is FAS. The drug target pathway of the drug is Apoptosis regulation.
The drug Sensitivity of the drug on the cell line is Resistant. The drug will not inhibit the growth of the cell line.
Reasoning:
The drug C-75 is a drug that inhibits the topoisomerase I. The drug target of the drug is FAS. The drug target path"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARM1, PIKFY2, MED12, CBL, RIBO1, MYC, PIK3CA, PTEN, SNCAIP, AR, BRAF, BRCA1, CSF3R, CD79A, CARD11, CDK12, CREBBP, CSF3, DOT1L, ETV5, EWSR1, FANCA, FBXW7, FGF12, FLT1, FUBP1, GNA11, GNA13, GRM3, HGF, IRF2, IRS2, JAK1, KDM5A, KDM5C, KEL, MLL2, MAP3K1, MEN1, MLH1, MSH6, MST1R, MTOR, MYB, NF2, NOTCH1, NOTCH3, PARP1, PBRM1, PIK"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALVOCIDIB. The drug SMILES structure is CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is Unknown.
The mutations present in the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. Based on the mutations present in the cell line, the drug sensitivity can be predicted as Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be predicted based on the drug target pathway. The drug target pathway is Unknown.
Reasoning:
The drug Sensitivity of the drug on the cell line with the given mutations can be predicted based on the mutations present in the cell line. The drug target pathway is Unknown.
Based on the mutations present in the cell line, the drug Sensitivity can be predicted as Resistant. The drug"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets the class I HDAC enzymes. The drug target pathway is Chromatin histone acetylation. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets class I HDAC, which are involved in the regulation of chromatin structure and gene expression. The drug target pathway is Chromatin histone acetylation. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is a kinase inhibitor that targets BTK, FGB, KIT, MLL2, MERTK, NFKBIA, PIK3C, RAC1, RAC2, SMARCA4, TET2, TP53. The drug target is MRE11, MLL2. Drug target pathway is DNA double-strand break repair, DNA damage response.
In summary, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations, and the drug is likely to be resistant to the cell line."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is PERK, which is a metabolism-related pathway. The mutations of the cell line are not related to the drug target or metabolism. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SMILES structure indicates that the drug inhibits the PERK kinase, which is a member of the ERK signaling pathway. The drug target is the Perk protein, which is a protein kinase that is involved in the Unfolded Protein Response (UPR) pathway. The UPR pathway is a cellular response to protein misfolding and is activated when the protein folding capacity of the cell is exceeded. The UPR pathway can induce various cellular responses, including autophagy, to remove misfolded proteins.
The drug SMILES structure indicates that the drug inhibits the PERK kinase, which is a"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug SMILES structure indicates that the drug targets CDK4 and CDK6, both of which are involved in the regulation of cell cycle progression. The drug target pathway is Cell cycle.
The mutations present in the cell line, ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53, suggest that the cell line may have a defect in the NPM1 gene. However, the drug sensitivity of the drug on the cell line cannot be determined solely based on the mutations present in the cell line. The drug sensitivity of the drug on the cell line would require additional information, such as the concentration of the drug, the duration of exposure to the drug, and the cell line's growth conditions.
In summary, the drug sensitivity of the drug on the cell line with the given mutations cannot be determined based"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
Based on the drug and cell line mutations provided, the drug SMILES structure, and the drug target pathway, the drug Sensitivity of the drug on the cell line is expected to be Resistant.
The cell line mutations include ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug target of the drug is IDH1 (R132H). The drug target pathway is Metabolism.
The drug Sensitivity of the drug on the cell line can be determined by analyzing the effects of the drug on the cell line's growth and proliferation. Since the drug Sensitivity of the drug on the cell line is not determined, it can be assumed that the drug will not affect the cell line's growth and proliferation.
Reasoning:
The drug Sensitivity of the drug on the cell line can be determined by analyzing the effects of the drug on the cell line's growth and pro"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure provides no clues about the drug target or pathway, making it difficult to determine the drug sensitivity of the drug on the cell line. The mutations of the cell line, however, suggest that the drug may be sensitive to the drug. The drug target of the drug is unknown, and the drug target pathway is also unknown.
The drug target of the drug is a kinase. The drug target pathway is a kinase signaling pathway.
The mutations of the cell line, ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53, suggest that the drug may be sensitive to the drug. The drug target of the drug is unknown.
In conclusion, the drug sensitivity of the drug on the cell line is uncertain and requires further investigation. The drug target of the drug is unknown, and the drug target pathway is also unknown. The mutations of the cell line do not provide any clear indication of the drug sensitivity"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure provides no direct clues about the drug's target or mechanism of action, making it difficult to predict the drug sensitivity of the drug on the cell line. However, the mutations present in the cell line suggest that the drug may not be effective in this case.
The cell line mutations include ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug does not have a specific target or mechanism of action, making it unlikely that it will affect the mutated genes in the cell line.
In summary, the drug sensitivity of the drug on the cell line with given mutations can be predicted to be Resistant."
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a mTOR inhibitor. The drug target is mTOR, which is a key regulator of cell growth and metabolism. The drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug SMILES structure indicates that the drug is a mTOR inicator.
The drug Sensitivity of the drug on the cell line with given mutations can be determined based on the drug target and the mutations of the cell line. Since the drug target is mTOR, which is a key regulator of cell growth and metabolism, and the mutations of the cell line are related to the PI3K/MTOR signaling pathway, it is likely that the drug will be sensitive to the drug.
However,"
ACH-000067,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target, MEK5, is not affected by the mutations in the cell line. The drug target pathway is also unchanged. Therefore, the drug sensitivity of the drug on the cell line is likely to remain unchanged.
The cell line mutations are not related to the drug target or pathway. The mutations are ARAF, BTK, ETV5, NPM1, PIK3CA, PTPRO, RB1, RET, TP53. The drug target of the drug is MEK5.
The drug Sensitivity of the drug on the cell line is Resistant, based on the mutations of the cell line."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a kinase. The drug target pathway is Mitosis.
The cell line mutations are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a kinase. The drug target pathway is Mitosis.
Based on the drug SMILES structure and drug target, the drug is a kinase inhibitor. The cell line mutations are related to kinases and other signaling pathways. Therefore, the drug sensitivity of the drug on the cell line would be Resistant, as the drug target is a kinase, and the cell line mutations are related to kinases and other signaling pathways."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets JNK1. The drug target pathway indicates that the drug targets the mitogen-activated protein kinase (MAPK) pathway. The drug target pathway is not affected by the mutations of the cell line. Therefore, the drug sensitivity of the drug on the cell line is not affected by the mutations.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the drug target pathway and the mutations of the cell line. In this case, the drug target pathway is not affected by the mutations of the cell line. Therefore, the drug sensitivity of the drug on the cell line is determined by the drug target pathway and the mutations of the cell line.
Reasoning: The drug sensitivity of the drug on the cell line with given mutations is Resistant. The drug target pathway is JNK1. The drug target pathway is not affected by the mutations of the cell line. Therefore, the drug sensitivity of the drug on the cell line is determined by the drug target pathway and the mutations of the cell line. In this case, the drug sens"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARACATI is a kinase inhibitor. The drug target is CSF1R. The drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug SARACATI is a kinase inhibitor.
Based on the drug SMILES structure and the mutations of the cell line, the drug SARACATI is unlikely to affect the drug sensitivity of the cell line. The drug target is CSF1R, KIT, PDGFRA, PDGFRB. The drug target pathway is RTK signaling.
The drug SARACATI inhibits the CSF1R, KIT, PDGFRA, PDGFRB. The CSF1R is a kinase that is involved in the proliferation, survival, and migration of stem cells. The KIT is a kinase that is involved in"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BUPARLISIB. The drug SMILES structure is C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4. Drug target is PI3Kalpha, PI3Kdelta, PI3Kbeta, PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug SARACATIB. The drug target is AKT1, AKT2, AKT3, AXL. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity: Resistant.
Based on the SMILES structure and drug target, the drug is not likely to affect the drug sensitivity of the cell line. The drug target PI3Kalpha, PI3Kdelta, PI3Kbeta, PI3Kgamma. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Resistant.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity: Resistant.
The drug SARACATIB is a CDK4 inhibitor. Drug target is AKT1, AKT2, AKT3, AX"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALPELISIB. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug SMILES structure is a PI3Kalpha inhibitor. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Based on the drug structure and mutations of the cell line, the drug SENSITIVITY of the drug on the cell line is RESISTANT.
The drug SMILES structure indicates that the drug SMILES structure is a PI3Kalpha inhibitor. PI3Kalpha is a key enzyme in the PI3K/MTOR signaling pathway. The drug target pathway is PI3K/MTOR signaling. The drug target is PI3Kalpha.
The drug inhibits PI3Kalpha, which is a key enzyme in the PI3K/MTOR signaling pathway. The PI3Kalpha inhibition leads to the suppression of PI3K/MTOR signaling, which is essential for cell survival and proliferation. The suppression of P"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets Stearoyl-CoA desaturase. The drug target pathway is Other. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug is CAY10566.
Based on the drug target and mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug will not affect the cells if the drug target is not affected, and the mutations of the cell line may affect the drug target.
Reasoning: The drug target of the drug is Stearoyl-CoA desaturase. The drug target pathway is Other. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCCC(CC3)OC4=C(C=CC(=C4)F)Cl.
The drug target of the drug is not affected by the mutations of the cell line"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is Other. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or suppression of cell growth in the cell line, then the drug Sensitivity is Resistant. If the drug does not affect the cell line, then the drug Sensitivity is Sensitive.
In this case, the drug Sensitivity of the drug on the cell line is Resistant, as the drug causes suppression of cell growth in the cell line. The drug target of the drug is BMP. The drug target pathway is Other. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Reasoning:
The drug Sensitivity of the drug on the cell line with the given mutations"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a metal-based drug. The drug target is unknown. The drug target pathway is unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug Sensitivity of the drug on the cell line is unknown.
Based on the information provided, the drug Sensitivity of the drug on the cell line is Resistant. The drug Sensitivity of the drug on the cell line with given mutations is also Resistant, as the mutations are not related to the drug's target or pathway."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a HDAC inhibitor. The drug target is a lysine-specific demethylase. The drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug is a DOT1L. The drug target is DOT1L. The drug target pathway is Chromatin histone methylation.
Based on the drug SMILES structure and drug target, the drug is not affected by the mutations of the cell line. The drug SMILES structure indicates that the drug is a DOT1L inhibitor. The drug target is a lysine-specific demethylase. The drug target pathway is Chromatin histone methylation.
The drug is EPZ-5676. The drug SMILES structure is CC(C)N"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINCRISTINE. The drug SMILES structure is CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a vinca alkaloid. The drug target is unknown. The drug target pathway is unknown. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Based on the provided information, the drug sensitivity of the drug on the cell line is likely to be resistant. The drug SMILES structure does not provide any information about the drug target or pathway, which makes it difficult to determine the drug sensitivity on the cell line. The mutations of the cell line, ARID1A, CARD11, CDKN2C, JAK1, do not provide any information about the drug sensitivity of the drug on the cell line.
In summary, the drug sensitivity of the drug on the cell line is Resistant."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line depends on the mutations present in the cell line. The mutations mentioned in the drug and cell line mutations are ARID1A, CARD11, CDKN2C, JAK1. The ARID1A mutation is a loss of function mutation, which can lead to the disruption of the chromatin structure and the regulation of gene expression. The CARD11 mutation is a frameshift mutation, which can lead to the disruption of the protein structure and function. The CDKN2C mutation is a loss of function mutation, which can lead to the disruption of the cell cycle progression. The JAK1 mutation is a missense mutation, which can lead to the disruption of the protein function.
Based on the drug SMILES structure and the mutations present in the cell line, the drug sensitivity of the drug on the cell line is likely to be Resistant. The drug target of the drug is EGFR, which is a key component of the RTK pathway. The RTK pathway is involved in various cellular processes, including cell growth, differentiation, and survival. The disruption of the RTK pathway can lead to the disruption of these processes, which can result in the growth"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets RAC1, RAC2, RAC3. The drug target pathway is Cytoskeleton. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug is EHT-1864.
Based on the information provided, the drug Sensitivity of the drug on the cell line is Resistant. The drug Sensitivity is determined by the drug target pathway and the mutations of the cell line. In this case, the drug target pathway is Cytoskeleton, and the mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug target of the drug is RAC1, RAC2, RAC3. RAC1, RAC2, and RAC3 are involved in the cytoskeleton. The drug target of the drug is not affected by the mutations of the cell line.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the drug target pathway and the mutations of"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is kinases. The mutations of the cell line suggest that the drug target pathway may be affected.
The drug is not a targeted therapy, but a kinase inhibitor. The drug target is unknown. The drug target pathway is unknown.
Based on the information provided, the drug sensitivity of the drug on the cell line is likely to be resistant. The cell line mutations may affect the drug target pathway, but the drug target is unknown, and the drug target pathway is also unknown. Therefore, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-47. The drug SMILES structure is CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5. Drug target is BTK, BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is BTK, BMX. The drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug is a kinase inhibitor.
Based on the information provided, the drug Sensitivity of the drug on the cell line is Resistant. The cell line mutations ARID1A, CARD11, CDKN2C, JAK1 are not related to the drug target or drug SMILES structure. The drug target pathway is Other, kinases.
The drug inhibits the BTK, BMX. The BTK, BMX are kinases that are involved in the B-cell signaling pathway. The B-cell signaling pathway is important for the immune system.
The Resistant decision is based on the fact that the drug target is a kinase inhibitor, which is not related to the mutations of the cell"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets JAK2, JAK3. The drug target pathway is Other, kinases. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug is AZ960.
Based on the information provided, the drug Sensitivity of the drug on the cell line is Resistant. The drug Sensitivity is determined by the drug target pathway and the mutations of the cell line. In this case, the drug target pathway is Other, kinases, and the mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug target of the drug is JAK2, JAK3.
The drug target of the drug is JAK2, JAK3. The JAK2 and JAK3 are tykak kinases that play a crucial role in various cellular processes, including hematopoiesis, immune response, and inflammation. The JAK2 and JAK3 kinases are involved in the signaling of cytokines and growth factors, including those that are important for hematopoiesis"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target pathway is kinases. The mutations of the cell line suggest that the drug target is not affected by the mutations. Therefore, the drug sensitivity of the drug on the cell line is likely to be resistant."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WEHI-539. The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1.Cl. Drug target is BCL-XL. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target is BCL-XL. The drug target pathway is Apoptosis regulation. The mutations of the cell line, ARID1A, CARD11, CDKN2C, JAK1, do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is WEHI-539. The drug target is BCL-XL. The drug target pathway is Apoptosis regulation. The mutations of the cell line, ARID1A, CARD11, CDKN2C, JAK1, do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The reason for the drug sensitivity of the drug on the cell line is that the drug target BCL-XL is not affected by the mutations of the cell line."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets PIKFYVE, which is a PI3K-like kinase. PIKFYVE is a key regulator of lipid metabolism, and its inhibition has been shown to have antitumor effects. However, the drug SMILES structure does not provide information about the drug target pathway.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug Sensitivity of the drug on the cell line depends on the mutations present in the cell line. If the mutations are not related to the drug target pathway, the drug sensitivity of the drug on the cell line may be unaffected. However, if the mutations are related to the drug target pathway, the drug sensitivity of the drug on the cell line may be affected.
In this case, the drug Sensitivity of the drug on the cell line is Resistant, as the mutations present in the cell line (ARID1A, CARD11, CDKN2C, JAK1) are not related to the drug target"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SHIKONIN is a natural product that has been found to have anticancer properties. However, the drug SHIKONIN is not a targeted drug, meaning it does not target a specific cancer cell pathway or component. Therefore, the drug SHIKONIN is likely to affect cancer cells as well as non-cancerous cells, leading to unspecific effects.
The mutations of the cell line, ARID1A, CARD11, CDKN2C, JAK1, do not provide a clear indication of the drug sensitivity of the drug on the cell line. The drug SHIKONIN does not have a specific target, and it is not clear how the drug would affect the cell line with these mutations. Therefore, the drug SHIKONIN is likely to have unspecific effects on cancer cells, and the drug Sensitivity of the drug on the cell line is likely to be Resistant.
Reasoning:
The drug SHIKONIN is a natural product that has been found to have anticancer properties. However, the drug SHIKONIN is not a targeted drug, meaning it does not target a specific cancer cell pathway or component. Therefore, the drug SHIKONIN is likely to affect cancer cells as well as non-can"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is an anti-metabolite. The drug target pathway is other. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity on the cell line is likely to be Resistant. The drug target is an anti-metabolite, which is not directly related to the mutations of the cell line. However, the mutations of the cell line, ARID1A, CARD11, CDKN2C, JAK1, may affect the cell line's ability to repair DNA damage, leading to increased sensitivity to the drug.
Reasoning:
The drug SMILES structure indicates that the drug is an anti-metabolite. The drug target pathway is other. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity on the cell line is likely to be Resistant. The drug target is an anti-metabolite,"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CZC24832. The drug SMILES structure is CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3C(=NC(=N3)N)C(=C2)F. Drug target is PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is PI3Kgamma. The drug target pathway is PI3K/MTOR signaling.
The cell line mutations are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug is a PI3Kgamma (PIK3C2G) inhibitor.
Based on the drug SMILES structure and drug target, the drug is unlikely to affect the cell line with the given mutations. The drug target pathway is PI3K/MTOR signaling. The drug target is a kinase.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug does not affect the cell line, it is Sensitive. If the drug affects the cell line, it is Resistant.
Reasoning: The drug SMILES structure and drug target indicate that the drug is a PI3Kgamma inhibitor. The drug target pathway is PI3K/MTOR signaling."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a clonal mutation in the BCL2L1. The drug target is BCL2. The drug target pathway is Apoptosis regulation.
The cell line mutations are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug is a BCL2 inhibitor.
The drug Sensitivity: The drug Sensitivity of the drug on the cell line is Resistant. The drug will not inhibit the proliferation of the cell line with the mutations ARID1A, CARD11, CDKN2C, JAK1.
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant. The drug will not inhibit the proliferation of the cell line with the mutations ARID1A, CARD11, CDKN2"
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALISERTIB. The drug SMILES structure is COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line is Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a kinase. The drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is a kinase. The drug target pathway is Mitosis.
The drug is ALISERTIB. The drug SMILES structure is COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC. Drug target is AURKA. Drug target pathway is Mitosis.
The drug is not a kinase inhibitor, but a kinase activator. The drug target is a kinase. The drug target pathway is Mitosis."
ACH-000078,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a mTOR inhibitor. The drug target is mTOR. The drug target pathway is PI3K/MTOR signaling.
The cell line mutations are ARID1A, CARD11, CDKN2C, JAK1. The drug Sensitivity is Resistant.
The drug Sensitivity of the drug on the cell line with given mutations can be determined based on the drug target and the mutations present in the cell line. In this case, the drug target is mTOR, and the cell line mutations are ARID1A, CARD11, CDKN2C, JAK1. The drug Sensitivity of the drug on the cell line is Resistant, as the drug target is mTOR, which is not affected by the mutations in the cell line."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that CUDC-101 is a HDAC inhibitor. The drug target pathway is Unknown. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant. The drug target of CUDC-101 is HDAC1-10, EGFR, ERBB2. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SMILES structure is a kinase inhibitor. The drug target is a kinase, and the target pathway is a kinase pathway. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The drug is IMATINIB. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The drug sensitivity of the drug on the cell line is Resistant, based on the mutations of the cell line."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FTI-277. The drug SMILES structure is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets farnesyl-transferase, which is responsible for the FTI-277 drug target pathway. The drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug Sensitivity of the drug on the cell line is unknown, as the mutations of the cell line do not provide any information about the drug sensitivity.
FTI-277 is a Farnesyl-transferase inhibitor. Farnesyl-transferase is responsible for adding a farnesyl group to proteins to modify their structure and function. The addition of this group is important for the proper targeting of proteins to membranes. Farnesyl-transferase inhibitors are used to treat various cancers, including breast, lung, and prostate cancers.
In summary, the drug Sensitivity of the drug on the cell line is unknown, as the mutations of the cell line do not provide any information about the drug sensitivity. The drug target pathway is Other."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets the PDK1. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing the growth inhibition or induction of cell death. If the drug does not affect the growth of the cell line, then it is Sensitive. If the drug causes growth inhibition or induction of cell death in the cell line, then it is Resistant.
Reasoning: The drug SMILES structure indicates that the drug targets the PDK1. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARACATI is a kinase inhibitor. The drug target is CSF1R. The drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, PIK3R1, POLD1, TP53.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug SARACATI is a kinase inhibitor that inhibits the CSF1R. CSF1R is a member of the RELATED RECEPTORS FAMILY and is involved in the STAT3 signaling pathway. The drug SARACATI inhibits the CSF1R in vitro, meaning that it does not inhibit the CSF1R in vivo.
The mutations of the cell line, ERBB4, GNAS, NOTCH1, PIK3R1, POL"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is an alkylating agent that damages the DNA molecule. The drug target is DNA alkylating agent. The drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug is OXALIPLATIN.
Based on the SMILES structure and drug target, the drug is unlikely to affect the cell line. The drug target is DNA alkylating agent, which is not related to the cell line mutations. Therefore, the drug sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug SMILES structure indicates that the drug is an alkylating agent that damages the DNA molecule. The drug target is DNA alkylating agent. The drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug is OXALIPLATIN.
Based on the SMILES structure and drug target, the drug is unlikely to affect the cell line. The drug target is DNA alkylating agent, which is not related to"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets Stearoyl-CoA desaturase. The drug target pathway is Other. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug target and mutations of the cell line, the drug SMILES structure, and the drug target pathway, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or growth inhibition in the cell line, then the drug Sensitivity is Resistant. If the drug does not affect the cell line, then the drug Sensitivity is Sensitive.
In this case, the drug Sensitivity of the drug on the cell line is Resistant, as the drug does not affect the cell line. The drug target of the drug is Stearoyl-CoA desaturase, which is not related to the mutations of the cell line. Therefore, the drug does not target the underlying cause of the cell line mutations, and the drug Sensitivity"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets G9A, a chromatin histone methylation. The drug target pathway is Chromatin histone methylation. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug target and mutations of the cell line, the drug SUNC0642 is unlikely to affect the cell line. The drug SUNC0642 targets G9A, which is not related to the mutations of the cell line. Therefore, the drug SUNC0642 is Resistant for the cell line."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line depends on the mutations present in the cell line. The drug SMILES structure indicates that it is an anthracycline, which is a class of drugs that are commonly used to treat various types of cancer. However, the drug target of the drug is not specified, which makes it difficult to determine the drug sensitivity of the drug on the cell line.
The mutations present in the cell line, ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1, do not seem to be related to the drug SMILES structure or drug target. Therefore, the drug sensitivity of the drug on the cell line is uncertain and can be considered as Resistant.
Reasoning:
The drug sensitivity of the drug on the cell line can be determined by analyzing the mutations present in the cell line and their relationship with the drug target. In this case, the drug target is not specified, which makes it difficult to determine the drug sensitivity of the drug on the"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WHI-P97. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC. Drug target is JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets JAK3. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity: Resistant.
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is JAK3. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is AKT1, AKT2, and AKT3. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line remains unchanged.
The drug Sensitivity: Resistant.
Reasoning: The drug SMILES structure indicates that the drug target is AKT1, AKT2, and AKT3. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line remains unchanged. The drug is resistant to the cell line."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SUNITINIB is a kinase inhibitor that targets KIT, PDGFRA, KIT, PDGFRB, KIT, PDGFR C. The drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SMILES structure indicates that the drug REFAMETINIB is a MEK1, MEK2 inhibitor. The drug target pathway is ERK MAPK signaling.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant. The drug target of the drug is MEK1, MEK2. The drug target pathway is ERK MAPK signaling. The mutations of the cell line, ERBB4, GNAS, NOTCH1, SPEN, WT1, do not relate to the drug target or pathway of the drug. Therefore, the drug Sensitivity of the drug on the"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets ALK, CDK7, LTK, others. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug SMD14-99 is a kinase inhibitor that targets various kinases, including ALK, CDK7, LTK, others. The drug target pathway is Other, kinases. The mutations of the cell line do not seem to be related to the drug target or drug target pathway.
In conclusion, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations. The drug is SMD14-99, and the drug sensitivity of the drug on the cell line is Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets the MPS1 protein. The drug target pathway is Mitosis. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to remain unchanged.
The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The drug is MPS-1-IN-1. The drug SMILES structure indicates that the drug targets the MPS1 protein. The drug target pathway is Mitosis. The mutations of the cell line do not seem to affect the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to remain unchanged.
The drug Sensitivity: Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets SIRT1. The drug target pathway is Chromatin histone acetylation. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug target and mutations of the cell line, the drug SMILES structure, and the drug target pathway, the drug Sensitivity of the drug on the cell line is Resistant.
The drug SMILES structure indicates that the drug targets SIRT1. SIRT1 is a member of the NLRP family of proteins, which are involved in the regulation of inflammation and immunity. The drug target pathway is Chromatin histone acetylation. Chromatin histone acytolysis is a critical process in the regulation of gene expression, DNA repair, and cell proliferation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The mutations of the cell line are related to the PI3K/AKT signaling pathway. The PI3K/AKT signaling pathway is involved in cell survival, prol"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a PARP1 inhibitor. The drug target pathway is Genome integrity. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug and cell line mutations, the drug sensitivity of the drug on the cell line is likely to be resistant.
The PARP1 inhibitor is a DNA damage response (DDR) pathway drug. The DDR pathway is essential for maintain DNAs and preventing genetic instability. The DNAs are repaired by various pathways, including PARP1, PARP2, and others. The DNAs repair pathways are essential for maintaining genetic stability and preventing genetic disorders.
The DNAs repair pathways are also essential for preventing cancer development. Cancer development is associated with genetic instability, which can be caused by various factors, including DNA damage, genetic mutations, and epigenetic changes. The PARP1 inhibitor can increase the sensitivity of cancer cells to chemotherapy and radiation"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEFITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined by the mutations present in the cell line. The mutations GNAS, NOTCH1, SPEN, WT1 are not associated with the drug Sensitivity. The mutation ERBB4 is associated with the drug Sensitivity as ERBB4 is a member of the EGFR family, and the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line is determined by the EGFR pathway. The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line is determined by the EGFR family. The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line is determined by the EGFR signaling pathway. The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line is determined by the Drug Sensitivity Pathway. The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sens"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SALUBRINAL. The drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target is EIF2A. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SALUBRINAL is a glutathione analogue that is used to treat various types of cancer, including lung, breast, and ovarian cancer. The drug SMILES structure indicates that it is a complex molecule with multiple functional groups. The drug target is EIF2A, which is a key regulator of protein synthesis.
Based on the drug structure and target, it appears that SALUBRINAL is a non-specific drug that can affect various cellular processes. The drug SMILES structure does not provide any specific clues about the drug sensitivity of the drug on the cell line with given mutations.
The cell line mutations provided are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug Sensitivity of the drug on the cell line would depend on various factors, including the specific mutations of the cell line, the concentration of the drug, and the cellular pathways affected by the drug.
In summary, without additional information about the drug SALUBRINAL and the cell line mutations, it is not possible to determine the drug sensitivity of the drug on the cell line with certainty. However, based on the SMILES structure of"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FLUDARABINE. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined based on the mutations present in the cell line. The mutations GNAS, NOTCH1, SPEN, WT1 are not associated with drug sensitivity. However, ERBB4 mutations can lead to MEDIATED drug resistance. Therefore, in this case, the drug Sensitivity of the drug on the cell line is Resistant.
Reasoning: The drug Sensitivity of the drug on the cell line is determined by the mutations present in the cell line. In this case, the mutations GNAS, NOTCH1, SPEN, WT1 are not associated with drug sensitivity. However, ERBB4 mutations can lead to MEDIATED drug resistance. Therefore, in this case, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets EGFR, which is a common target for many drugs. However, the mutations of the cell line suggest that the drug may not be effective in this case. The ERBB4, GNAS, NOTCH1, SPEN, WT1 mutations do not seem to be directly related to the EGFR pathway, which suggests that the drug may still work even with these mutations. However, the drug Sensitivity of the drug on the cell line is decided by the drug target pathway, which in this case is EGFR. The drug target pathway is not affected by the mutations of the cell line. Therefore, the drug Sensitivity of the drug on the cell line is Resistant.
Reasoning: The drug Sensitivity of the drug on the cell line is Resistant because the mutations of the cell line do not seem to be directly related to the EGFR pathway, which is the target pathway of the drug. The drug Sensitivity is decided by the drug target pathway, which in this case is not affected by the mutations of the cell line. Therefore, the drug Sensitivity of the drug"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK269962. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. Based on the drug target and mutations of the cell line, the drug SMILES structure, and the drug target pathway, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or growth inhibition in the cell line, then the drug Sensitivity is Resistant. If the drug does not affect the cell line, then the drug Sensitivity is Sensitive.
In this case, the drug Sensitivity of the drug on the cell line is Resistant, as the drug causes growth inhibition in the cell line. The drug target of the drug is ROCK1, ROCK2. The drug target pathway is Cytoskeleton. The mutations of"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DMOG. The drug SMILES structure is COC(=O)CNC(=O)C(=O)OC. Drug target is HIF-PH. Drug target pathway is Metabolism.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a metabolic inhibitor. The drug target is HIF-PH, which is a metabolic pathway. The drug target pathway is Metabolism.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SMILES structure indicates that the drug is DMOG. The drug target is HIF-PH.
Based on the drug SMILES structure and drug target, the drug target pathway, and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug may not affect the cell line as the drug target is HIF-PH, which is not related to the metabolism of the cell line. The mutations of the cell line, ERBB4, GNAS, NOTCH1, SPEN, WT1, may not have a significant impact on the drug sensitivity of the cell line.
The drug may affect the cell line by inhibiting the HIF-PH, which may lead to the proliferation of the cell line. However, the mutations of the cell line may not have a significant impact on the drug sensitivity of the cell line.
In summary, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug OTX015 is a kinase inhibitor. The drug target is BRD2. The drug target pathway is Chromatin other. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with the given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or growth inhibition in the cell line, then the drug Sensitivity is Resistant. If the drug does not affect the cell line, then the drug Sensitivity is Sensitive.
In this case, the drug Sensitivity of the drug on the cell line is Resistant, as the drug does not affect the cell line. The drug target of the drug is BRD2, which is a different target than the target of the drug SMILES structure. The drug target pathway of the drug is Ch"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets PIKFYVE, which is a PI3K-like enzyme. The drug SMILES structure does not provide any information about the drug target pathway. The drug target pathway is not affected by the mutations in the cell line. Therefore, the drug sensitivity of the drug on the cell line would not be affected by the mutations.
The drug Sensitivity: The drug Sensitivity of the drug on the cell line would depend on the specific mutations present in the cell line. As the mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug Sensitivity of the drug on the cell line would be Sensitive.
Reasoning: The drug SMILES structure indicates that the drug targets PIKFYVE, which is a PI3K-like enzyme. The drug target pathway is not affected by the mutations in the cell line. Therefore, the drug sensitivity of the drug on the cell line would not be affected by the mutations. The drug Sensitivity of the drug"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug does not have a target or a known mechanism of action. The drug target pathway is also unknown. Based on the mutations of the cell line, the drug SMILES structure, and the drug target pathway, the drug is unlikely to affect the cell line. Therefore, the drug sensitivity of the drug on the cell line is Resistant.
Reasoning:
The drug Sensitivity of the drug on the cell line can be determined by analyzing the mutations of the cell line. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug does not have a target or a known mechanism of action. The drug target pathway is also unknown. Based on these factors, the drug is unlikely to affect the cell line. Therefore, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with given mutations depends on the specific mutations present in the cell line. For example, if the mutations are ERBB4, GNAS, NOTCH1, SPEN, WT1, the drug may be Sensitive. However, if the mutations are DAPK3, CLK4, PIM3, HIPK2, the drug may be Resistant.
The drug Sensitivity of the drug on the cell line can be determined by analyzing the effects of the drug on the cell line's growth and viability. The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the effects"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is an anti-metabolite. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug and cell line mutations, the drug sensitivity of the drug on the cell line is Resistant.
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)F. Drug target is Breast cancer cell proliferation. Drug target pathway is Unknown.
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug is LEFLUNOMIDE. Based"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined by the mutations present in the cell line. The mutations GNAS, NOTCH1, SPEN, WT1 are not associated with the drug Sensitivity. The mutation ERBB4 is associated with the drug Sensitivity as ERBB4 is a SMART (SMARCA4) gene that is commonly mutated in various cancers, including NUTM1, ATR, BRAF, KIT, KLHL6, MLL, MLL2, MAP2K1, PIK3C2G, ROS1, TET2, TP53.
The drug Sensitivity of the drug on the cell line is Resistant as the drug Sensitivity is determined by the mutations present in the cell line. The mutations present in the cell line do not associate with the drug Sensitivity.
The drug S"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MASITINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5. Drug target is KIT, PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets KIT, PDGFRA, PDGFRB. The drug target pathway is RTK signaling. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on this information, the drug sensitivity of the drug on the cell line is likely to be resistant.
The drug SMILES structure does not provide any information about the drug target or pathway. Therefore, the drug target pathway is not available.
The drug target pathway is RTK signaling.
The drug target is KIT, PDGFRA, PDGFRB.
Drug target pathway is RTK signaling.
The drug is MASITINIB.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug is MASITINIB.
The drug target is KIT, PDGFRA, PDGFRB.
Drug target pathway is RTK signaling.
The drug target is ERBB4.
"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug is a product of a redox reaction. The drug target, PI3K, is a key regulator of PI3K/MTOR signaling. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug is not a kinase inhibitor. The drug is a product of a redox reaction.
Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant. The drug target pathway is not affected by the drug target. The mutations of the cell line do not affect the drug target.
Reasoning:
The drug is not a kinase inhibitor, and the drug target is PI3K. The drug target pathway is not affected by the drug target. The mutations of the cell line do not affect the drug target. The drug is a product of a redox reaction.
Based on the above analysis, the drug Sensitivity of the drug on the cell line is Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets MTOR, ATR. The drug target pathway is Other. The mutations of the cell line, ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1, do not seem to be related to the drug target of the drug. Therefore, the drug sensitivity of the drug on the cell line with these mutations is uncertain, and the drug is likely to be resistant to the drug.
Reasoning:
The drug SMILES structure indicates that the drug targets MTOR, ATR. The drug target pathway is Other. The mutations of the cell line, ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1, do not seem to be related to the drug target of the drug. Therefore, the drug sensitivity of the drug on the cell line with these mutations is uncertain, and the drug is likely to be resistant to the drug.
Drug Sensitivity: Resistant."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-8776. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that MK-8776 is a CHEK1, CHEK2, CDKN2A, FLCN, GATA6, IGF1R, RBM10, TP53, ZNF217 mutant. Based on the drug Sensitivity and mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line is determined by the mutations present in the cell line. The mutations present in the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug Sensitivity of the drug on the cell line is Resistant, as the drug SMILES structure indicates that the drug target is CHEK1, CHEK2, CDKN2A, CDKN2B, FLCN, GATA6, IGF1R, RBM10, TP53, WT1. The mutations present in the cell line do not match the drug target, indicating that the drug will not be effective on the cell line."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. Based on the drug target and mutations of the cell line, the drug SMILES structure, and the drug target pathway, the drug sensitivity of the drug on the cell line is Resistant.
The drug SMILES structure indicates that the drug target is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. Based on the drug target and mutations of the cell line, the drug Sensitivity is Resistant.
The drug is AZD4547. The drug target is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling. The"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CEDIRANIB. The drug SMILES structure is CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5. Drug target is VEGFR, FLT1, FLT2, FLT3, FLT4, KIT, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug CEDIRANIB is a VEGFR inhibitor that is used to treat cancer. VEGFR inhibitors work by blocking the growth of new blood vessels, which are essential for the survival and spread of tumors. However, not all tumors are dependent on VEGFR signaling, and some tumors may even be resistant to VEGFR inhibitors.
The cell line mutations provided by the user include ERBB4, GNAS, KIT, MLL2, KRAS, MSH2, TP53. The drug SMILES structure indicates that the drug inhibits VEGFR, FLT1, FLT2, FLT3, FLT4. The drug target pathway is RTK signaling.
Based on the provided information, the drug Sensitivity of the drug on the cell line is Resistant. The cell line mutations include ERBB4, GNAS, KIT, MLL2, KRAS, MSH2, TP53. The drug"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a statin, which is a cholesterol-lowering drug. The drug target is unknown. The drug target pathway is unknown.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SMILES structure indicates that the drug is a statin, which is a cholesterol-lowering drug. The drug target is unknown. The drug target pathway is unknown.
Based on the drug SMILES structure and the mutations of the cell line, the drug sensitivity of the drug on the cell line can be predicted as Resistant. The drug target of the drug is not related to the mutations of the cell line. Therefore, the drug will not be affected by the mutations of the cell line.
Reasoning:
The drug SMILES structure indicates that the drug is a statin, which is a cholesterol-lowering drug. The drug target is unknown."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug target is mTOR. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug target, drug target pathway, and mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line can be determined by analyzing the drug target of the drug and the mutations of the cell line. If the drug target is affected by the mutations of the cell line, the drug Sensitivity of the drug on the cell line will be Resistant. Otherwise, the drug Sensitivity of the drug on the cell line will be Sensitive.
In this case, the drug target of the drug is mTOR. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is PKD. The drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug SMILES structure indicates that the drug is a kinase inhibitor.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line depends on the effect of the mutations on the cell line. If the mutations are neutral or have a positive effect on the cell line, the drug Sensitivity will be Sensitive. However, if the mutations have a negative effect on the cell line, the drug Sensitivity will be Resistant.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the effect of the drug on the cell line. If the drug causes cell death or inhibits cell growth, the drug Sensitivity is Resistant. However, if the drug has no effect on the cell line, the drug Sensitivity is Sensitive.
In summary, the drug Sensitivity"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug targets a class of enzymes called proteins. The drug target pathway is Metabolism. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug Sensitivity of the drug on the cell line can be determined by testing the drug on the cell line and observing its effect on cell growth and viability. If the drug does not affect the cell line, it is Sensitive. If the drug causes cell death or growth inhibition, it is Resistant.
Reasoning: The drug SMILES structure indicates that the drug targets a class of enzymes called proteins. The drug target pathway is Metabolism. The mutations of the cell line do not seem to be related to the drug target or pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations."
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SPHINGOSINE KINASE 1 INHIBITOR II. The drug SMILES structure is CC1=CC(=CC(=C1)OCC2=CC=C(C=C2)CN3CCC[C@@H]3CO)CS(=O)(=O)C4=CC=CC=C4. Drug target is Sphingosine Kinase. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug SPHINGOSINE KINASE 1 INHIBITOR II inhibits the Sphingosine kinase. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Based on the drug and cell line mutations, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the effects of the drug on the cell line. If the drug causes cell death or growth inhibition in the cell line, then the drug Sensitivity is Resistant. If the drug does not affect the cell line, then the drug Sensitivity is Sensitive.
In this case, the drug Sensitivity of the drug on the cell line is Resistant, as the drug SPHINGOSINE KINASE 1 INHIBITOR II does not affect the cell line. The drug target pathway of the drug is Other, kinases. The mutations"
ACH-000105,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SGC0946 is a kinase inhibitor that targets ERBB4, ERBB2, ERBB1. The drug SMILES structure indicates that the drug targets the DOT1L, a Chromatin histone methylation. The drug target pathway is Chromatin histone methylation.
The cell line mutations are ERBB4, GNAS, NF1, PTEN, RB1, SPEN. The drug Sensitivity is Resistant.
Based on the drug and cell line mutations, the drug SGC0946 is likely to be resistant to the cell line. The drug target is DOT1L, which is a Chromatin histone methylation. The drug target pathway is Chromatin histone methylation. The cell line mutations are ERBB4, GNAS, NF1, PTEN, RB1, SPEN. The drug Sensitivity is Resistant.
The drug SGC0946 inhibits the CHEK1, CHEK2"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug is a kinase inhibitor. The drug target is IDH2(R140Q). The drug target pathway is Metabolism.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug SMILES structure indicates that the drug is a kinase inhibitor.
Based on the drug SMILES structure and the mutations of the cell line, the drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity of the drug on the cell line with given mutations can be determined by analyzing the drug target pathway and the mutations present in the cell line. In this case, the drug target pathway is Metabolism, and the mutations present in the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug SMILES structure indicates that the drug is a kinase inhibitor.
The drug Sensitivity of the"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARM1, AKT1, AXL, CASP8, CBL, CSF1R, DDR2, EPHB1, MLL, MLL2, MED12, MTOR, NBN, PDK1, PMS2, RET, RPTOR, SMAD2, SOCS1, TYRO3 are the drug target and pathway. The drug target pathway is Other.
The mutations of the cell line are ABL1, CDKN2A, CSF1R, CUL4A, DDR1, HGF, KDM5A, MLL2, MSH2, MTOR, NTRK1, PIK3C2B, PIK3CA, POLE, ROS1, SMAD4, STAG2, TP53.
The drug Sensitivity of the drug on the cell line with given mutations is Resistant. The drug SARM1, AKT1, AXL, CASP8, CBL, CSF"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SMILES structure is a kinase inhibitor. The drug target is a kinase, and the drug target pathway is Other, kinases. The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug Sensitivity of the drug on the cell line is Resistant.
The drug SMILES structure indicates that the drug SMILES structure is a tyrosine kinase inhibitor. The drug target is a kinase. The drug target pathway is Other, kinases. The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug Sensitivity of the drug on the cell line is Resistant.
The drug SMILES structure indicates that the drug SMILES structure is a metabolic drug. The drug target is a metabolic pathway. The drug target pathway is Other, metabolism. The mutations of the cell line are ABL"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug SMILES structure indicates that it targets IGF1R. The drug target pathway is IGF1R signaling.
The mutations present in the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug SMILES structure indicates that it targets IGF1R. The drug target pathway is IGF1R signaling.
Based on the mutations present in the cell line, the drug sensitivity can be predicted as Resistant. The drug target pathway indicates that the drug targets a specific pathway, but the mutations in the cell line may affect the expression of this pathway, leading to resistance to the drug.
Reasoning:
The drug SMILES structure indicates that it targets IGF1R. The drug target pathway is IGF1R signaling. The mutations present in the cell line, such as ABL1, CDKN2A, F"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug SMILES structure indicates that it targets VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. The drug target pathway is RTK signaling.
The mutations present in the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug target of the drug is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. The drug target pathway is RTK signaling.
Based on the mutations present in the cell line, the drug sensitivity can be predicted as Resistant. The drug target of the drug is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. The drug target pathway is RTK signaling.
The drug target pathway"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets the BTK protein. The drug target pathway is Other, kinases. The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug is LFM-A13.
Based on the drug SMILES structure and drug target, the drug is targeted towards the BTK protein. The BTK protein is a crucial component of the B-cell receptor signaling pathway. The BTK protein is involved in the signaling of ITCH, HELTH4, and PIM1. The BTK protein is mutated in many cancers, including CLL, NHL, and others.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug SMILES structure indicates that the drug targets the BTK protein. The drug target pathway is Other, kinases.
Based on the drug SMILES structure and drug target, the drug is targeted towards the BTK protein. The BTK protein is a crucial component of the B-cell receptor signal"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug Sensitivity of the drug on the cell line is Resistant.
The drug Sensitivity is determined based on the mutations present in the cell line. The mutations present in the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)Cl)Drug Target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug Target Pathway is RTK signaling.
The drug Sensitivity of the drug on the cell line is determined based on the mutations present in the cell line. Since the mutations present in the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53, the drug Sens"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug sensitivity of the drug on the cell line is likely to be resistant. The cell line mutations include ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug target of the drug is FLT3, JAK2, NTRK1, NTRK2, NTRK3. The drug target pathway is Other, kinases.
The drug Sensitivity of the drug on the cell line would be resistant as the drug target is not affected by the mutations in the cell line. The mutations in the cell line are not related to the drug target of the drug. Therefore, the drug would not be effective on the cell line, and the drug sensitivity would be resistant."
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug SMILES structure indicates that the drug targets ERK1 and ERK2, which are members of the Mitogen-activated protein kinase (MAPK) pathway. The drug SMILES structure does not provide any information about the drug target pathway. The mutations of the cell line do not seem to be related to the drug target pathway. Therefore, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations.
The drug is a kinase inhibitor that targets ERK1 and ERK2. The drug target pathway is MAPK signaling. The mutations of the cell line are related to ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug target of the drug is ERK1, ERK2. Drug target pathway is MAPK signaling.
In conclusion, the drug sensitivity of the drug on the cell line is likely to be unaffected by the mutations. The drug target pathway is MAPK signaling, which is not related to the mutations of the cell line"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TANESPIMYCIN. The drug SMILES structure is CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Resistant,"Resistant.
The drug sensitivity of the drug on the cell line with the given mutations can be determined based on the mutations present in the cell line. The drug Sensitivity of the drug on the cell line would be Resistant, as the cell line has mutations in the ABL1, KRAS, FANCC, RNF43 and TP53 genes. These mutations may lead to uncontrolled cell growth and resistance to the drug."
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SALUBRINAL. The drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target is EIF2A. Drug target pathway is Other.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SALUBRINAL is a glutathione analogue that is used to treat various types of cancer, including lung, breast, and ovarian cancer. The drug SMILES structure indicates that it is a complex molecule with multiple functional groups. The drug target is EIF2A, which is a key regulator of protein synthesis.
Based on the mutations of the cell line, the drug SALUBRINAL is unlikely to be effective on this cell line. The cell line has mutations in the ABL1, CDKN2A, FANCC, KRAS, and RNF43 genes. The drug SALUBRINAL does not target any of these genes, and therefore, the drug is unlikely to be affected by the mutations in these genes.
However, the drug SALUBRINAL does target the EIF2A, which is a key regulator of protein synthesis. EIF2A is a key enzyme that is involved in the translation of mRNA into protein. The mutations in the cell line, such as ABL1, CDKN2A, FANCC, KRAS, RNF43,"
ACH-000107,"<s>[INST] <<SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line: [Sensitive/Resistant]<</SYS>>Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?[/INST]",Sensitive,"Resistant.
The drug SMILES structure indicates that the drug SARM1, SARM1LT, SARM1R are not relevant to the JAK2 and JAK2V mutations in the cell line. The drug target pathway is also not relevant to the cell line mutations.
The cell line mutations ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53 do not provide any information about the drug sensitivity of the drug on the cell line. The drug SMILES structure does not contain any mutations related to the drug.
Based on the information provided, the drug SARM1 does not have any relevant mutations related to the drug SMILES structure or drug target pathway in the cell line. Therefore, the drug sensitivity of the drug on the cell line is Resistant."
